S100A6 and S100A10 demonstrated tumor-specific hypermethylation in medulloblastoma primary tumors and cell lines, which was associated with their transcriptional silencing, while decreased S100A10 expression associated with increased promoter CpG methylation was noted in primary human pituitary tumors [17, 18]. This evidence concerns the gene S100A10 and medulloblastoma.